Morgan Stanley Inovio Pharmaceuticals, Inc. Transaction History

Morgan Stanley

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Aug 16, 2024	BUY	$0.35 - $0.53 $189,593 - $287,098	541,696 New	541,696 $276,000
Q4 2023 Feb 13, 2024	BUY	$0.35 - $0.53 $83,110 - $125,853	237,459 Added 78.05%	541,696 $276,000
Q3 2023 Nov 15, 2023	SELL	$0.38 - $0.58 $27,527 - $42,015	-72,440 Reduced 19.23%	304,237 $118,000
Q2 2023 Aug 14, 2023	SELL	$0.39 - $0.94 $55,418 - $133,573	-142,099 Reduced 27.39%	376,677 $169,000
Q1 2023 May 15, 2023	SELL	$0.79 - $1.91 $583,575 - $1.41 Million	-738,703 Reduced 58.74%	518,776 $425,000
Q4 2022 Feb 14, 2023	SELL	$1.41 - $2.5 $49,875 - $88,432	-35,373 Reduced 2.74%	1,257,479 $1.96 Million
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $2.38 Million - $4 Million	-1,434,237 Reduced 52.59%	1,292,852 $2.23 Million
Q2 2022 Oct 27, 2022	BUY	$1.44 - $3.98 $1.54 Million - $4.27 Million	1,072,778 Added 64.85%	2,727,089 $4.72 Million
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $1.54 Million - $4.27 Million	1,072,778 Added 64.85%	2,727,089 $4.72 Million
Q1 2022 Oct 27, 2022	SELL	$2.97 - $5.2 $3.19 Million - $5.58 Million	-1,072,778 Reduced 39.34%	1,654,311 $5.94 Million
Q1 2022 May 13, 2022	BUY	$2.97 - $5.2 $3.35 Million - $5.87 Million	1,128,831 Added 214.82%	1,654,311 $5.94 Million
Q4 2021 Feb 14, 2022	SELL	$4.99 - $7.46 $1.06 Million - $1.58 Million	-211,906 Reduced 28.74%	525,480 $2.62 Million
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $5.28 Million - $7.15 Million	737,386 New	737,386 $5.28 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $521M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.